Esscubes Medisiences Private Limited
Wholesale distribution of pharmaceutical products and medical equipment in India and abroad.
2012 | Bangaluru, Karnataka (India) | Active
Esscubes Medisiences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 13 Year, 25 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -25.16%
- Profit Growth -1874.01%
- Ebitda -983.28%
- Net Worth -113.60%
- Total Assets -15.25%
About Esscubes Medisiences
Esscubes Medisiences Private Limited (EMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 February 2012 and has a history of 13 years. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sowmya Prasad and Rajendra Porasad serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U36912KA2012PTC062395
- Company No.
062395
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Pharma
Who are the key members and board of directors at Esscubes Medisiences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sowmya Prasad  | Director | 03-Feb-2012 | Current |
| Rajendra Porasad | Director | 11-Dec-2013 | Current |
Financial Performance of Esscubes Medisiences.
Esscubes Medisiences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 25.16% decrease. The company also saw a substantial fall in profitability, with a 1874.01% decrease in profit. The company's net worth observed a substantial decline by a decrease of 113.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Esscubes Medisiences?
In 2021, Esscubes Medisiences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Amrita Pharma Sales Llp
Sowmya Prasad is a mutual person
- Theertankar Pharma Private Limited
Sowmya Prasad and Rajendra Porasad are mutual person
- Sumendum Pharma Private Limited
Rajendra Porasad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Esscubes Medisiences?
Unlock and access historical data on people associated with Esscubes Medisiences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Esscubes Medisiences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esscubes Medisiences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
